Compare VOR & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | NAGE |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 386.0M |
| IPO Year | 2021 | N/A |
| Metric | VOR | NAGE |
|---|---|---|
| Price | $13.76 | $4.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $64.78 | $16.00 |
| AVG Volume (30 Days) | 576.6K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.75 |
| Revenue Next Year | N/A | $19.96 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $4.72 |
| 52 Week High | $49.95 | $14.66 |
| Indicator | VOR | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 45.51 | 36.91 |
| Support Level | $11.27 | $4.73 |
| Resistance Level | $14.73 | $5.32 |
| Average True Range (ATR) | 1.13 | 0.31 |
| MACD | -0.20 | 0.01 |
| Stochastic Oscillator | 16.12 | 29.14 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.